|
|
Volumn 3, Issue 9, 2004, Pages 731-732
|
|
Cardiovascular combinations
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ACETYLSALICYLIC ACID;
AMLODIPINE;
AMLODIPINE BESYLATE;
AMLODIPINE PLUS ATORVASTATIN;
AMLODIPINE PLUS BENAZEPRIL;
ANTILIPEMIC AGENT;
ATACAND HCT;
ATORVASTATIN;
AVALIDE;
BENAZEPRIL PLUS HYDROCHLOROTHIAZIDE;
BENDROFLUMETHIAZIDE PLUS NADOLOL;
BENICAR HCT;
BISOPROLOL FUMARATE PLUS HYDROCHLOROTHIAZIDE;
CANDESARTAN HEXETIL;
DILTIAZEM PLUS ENALAPRIL MALEATE;
ENALAPRIL MALEATE PLUS FELODIPINE;
ENALAPRIL PLUS HYDROCHLOROTHIAZIDE;
EPROSARTAN;
EZETIMIBE;
EZETIMIBE PLUS SIMVASTATIN;
HYDROCHLOROTHIAZIDE;
HYDROCHLOROTHIAZIDE PLUS LISINOPRIL;
HYDROCHLOROTHIAZIDE PLUS LOSARTAN;
HYDROCHLOROTHIAZIDE PLUS QUINAPRIL;
HYDROCHLOROTHIAZIDE PLUS TELMISARTAN;
HYDROCHLOROTHIAZIDE PLUS VALSARTAN;
IRBESARTAN;
MICARDIS HCT;
MOEXIPRIL;
OLMESARTAN;
PRAVASTATIN;
PRAVIGARD PAC;
QUINAPRIL;
SIMVASTATIN;
TEVETEN HCT;
TIMOLIDE;
TIMOLOL;
TORCETRAPIB;
TRANDOLAPRIL PLUS VERAPAMIL;
UNCLASSIFIED DRUG;
UNIRETIC;
ANTIHYPERTENSIVE THERAPY;
CARDIOVASCULAR DISEASE;
DRUG APPROVAL;
DRUG EFFICACY;
DRUG MARKETING;
DYSLIPIDEMIA;
FOOD AND DRUG ADMINISTRATION;
HUMAN;
HYPERTENSION;
NOTE;
PATIENT COMPLIANCE;
PRIORITY JOURNAL;
ANTIHYPERTENSIVE AGENTS;
CARDIOVASCULAR AGENTS;
CARDIOVASCULAR DISEASES;
DRUG COMBINATIONS;
DRUG INDUSTRY;
HUMANS;
|
|
EID: 4544265949
PISSN: 14741776
EISSN: None
Source Type: Journal
DOI: 10.1038/nrd1501 Document Type: Note |
|
Times cited : (26)
|
|
References (5)
|
